Sep 2026· Antioxidants and Redox Signaling· Vol 45, pp. 857 - 878· 0 citations· 127 references
Medicine
TL;DR
Understanding mitochondrial microautophagy may reveal new therapeutic opportunities for mitochondrial dysfunction-associated disorders, including neurodegeneration, ischemic injury, metabolic disorders, and aging.
Abstract
Background:
Mitochondrial quality control has traditionally been attributed to mitophagy. However, emerging evidence indicates that mitochondrial microautophagy represents a distinct quality control pathway. This pathway enables selective removal of damaged mitochondrial subdomains while preserving overall organelle integrity. Therefore, mitochondrial microautophagy can be viewed as a redox-adaptive, sub-organelle quality control system that responds to localized mitochondrial stress.
Scope of Review:
In this review, we integrate recent mechanistic, imaging, and molecular studies to establish an updated framework of mitochondrial microautophagy. We describe this process as a sequential pathway involving damage sensing, mitochondria–lysosome contact formation, lysosomal membrane remodeling, selective degradation, and metabolic recycling. Localized reactive oxygen species (ROS) serve as important signals during this process. ROS define specific damage microdomains and facilitate selective mitochondrial component recognition. Subsequent cargo delivery and degradation are regulated by multiple molecular modules. These modules include the ubiquitin–autophagy-related protein 8 system, vacuolar-type H+-ATPase-dependent membrane remodeling, Ras-related in brain–endosomal sorting complexes required for transport signaling, the spermatogenesis-associated 18/mitochondria-eating protein pathway, and the mechanistic target of rapamycin complex 1–transcription factor EB and nuclear factor erythroid 2–related factor 2 stress-response networks.
Outstanding Questions:
Despite substantial progress, several fundamental questions remain unresolved. The mechanisms underlying cargo recognition require further clarification. The existence of specific redox-sensitive receptors remains to be determined. In addition, future technological advances will provide deeper insights into this pathway.
Conclusions:
Understanding mitochondrial microautophagy may reveal new therapeutic opportunities for mitochondrial dysfunction-associated disorders, including neurodegeneration, ischemic injury, metabolic disorders, and aging. Antioxid. Redox Signal. 45, 857–878.
Current understanding of mitochondrial DUBs in physiology and disease is synthesized and emerging pharmacological strategies to guide the development of mitophagy-targeted therapeutics are discussed.
Yang Xu, Bahareh Behrouz, Andrew Lee et al.· TIPS - Trends in Pharmacolog...· 0 citations
This work resolves the long-standing ambiguity between TBC1D15 total expression level and its subcellular shuttling, establishing a new conceptual framework that prioritizes protein translocation over bulk abundance in organelle quality control.
Peng-Fei Qiang, Yan Li, Shuang Liang et al.· Cells· 0 citations
Ten key PTMs, including lactylation, succinylation, succinylation, SUMOylation, and S-nitrosylation, acting on core regulators such as dynamin-related protein 1(DRP1), optic atrophy 1 (OPA1), Parkin, and mitochondrial Rho GTPase 1 (MIRO1) are summarized to provide a comprehensive resource for understanding mitochondria...
Haolin Ding, E. Taoxia, Jing-Cai He et al.· Element· 0 citations
A potential role for an mTORC2-cytoskeleton-mitochondrial positioning axis as a regulatory module underlying spatially confined oxidative injury is suggested and new insights into how subcellular organization shapes redox-dependent cell fate decisions are provided.
Zhen-Hong He, Yi-Shu Zhong, Yu-Han Luo et al.· Cell Death Discovery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.